Amphastar Pharmaceuticals (AMPH) Analyst & Key Data

Analyst Consensus

Hold6 analysts

Hold

Updated Sep 12, 2026

Total Analysts6

Buy

3

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$23.78

Median Target-5.38%

$22.50

Potential downside vs current price

Current Stock Price

$23.78

Median Target-5.38%

$22.50

Potential downside vs current price

Analyst Consensus

Hold6 analysts

Hold

Updated Sep 12, 2026

Total Analysts6

Buy

3

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$23.78

Median Target-5.38%

$22.50

Potential downside vs current price

Current Stock Price

$23.78

Median Target-5.38%

$22.50

Potential downside vs current price

Amphastar Pharmaceuticals, Inc.